Literature DB >> 31734231

Mycobacterial Trehalose 6,6'-Dimycolate-Induced M1-Type Inflammation.

Thao K T Nguyen1, John d'Aigle1, Luis Chinea2, Zainab Niaz2, Robert L Hunter2, Shen-An Hwang2, Jeffrey K Actor3.   

Abstract

Murine models of Mycobacterium tuberculosis (Mtb) infection demonstrate progression of M1-like (proinflammatory) and M2-like (anti-inflammatory) macrophage morphology following primary granuloma formation. The Mtb cell wall cording factor, trehalose 6,6'-dimycolate (TDM), is a physiologically relevant and useful molecule for modeling early macrophage-mediated events during establishment of the tuberculosis-induced granuloma pathogenesis. Here, it is shown that TDM is a major driver of the early M1-like macrophage response as seen during initiation of the granulomas of primary pathology. Proinflammatory cytokines tumor necrosis factor-α, IL-1β, IL-6, and IL-12p40 are produced in lung tissue after administration of TDM to mice. Furthermore, CD11b+CD45+ macrophages with a high surface expression of the M1-like markers CD38 and CD86 were found present in regions of pathology in lungs of mice at 7 days post-TDM introduction. Conversely, only low phenotypic marker expression of M2-like markers CD206 and EGR-2 were present on macrophages. These findings suggest that TDM plays a role in establishment of the M1-like shift in the microenvironment during primary tuberculosis.
Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31734231      PMCID: PMC7013273          DOI: 10.1016/j.ajpath.2019.10.006

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  65 in total

1.  Differential control of Mincle-dependent cord factor recognition and macrophage responses by the transcription factors C/EBPβ and HIF1α.

Authors:  Hanne Schoenen; Alexandra Huber; Nada Sonda; Stephanie Zimmermann; Jonathan Jantsch; Bernd Lepenies; Vincenzo Bronte; Roland Lang
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

Review 2.  For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection.

Authors:  Anca Dorhoi; Stephen T Reece; Stefan H E Kaufmann
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

Review 3.  Evasion of Innate and Adaptive Immunity by Mycobacterium tuberculosis.

Authors:  Michael F Goldberg; Neeraj K Saini; Steven A Porcelli
Journal:  Microbiol Spectr       Date:  2014-10

Review 4.  Macrophage immunoregulatory pathways in tuberculosis.

Authors:  Murugesan V S Rajaram; Bin Ni; Claire E Dodd; Larry S Schlesinger
Journal:  Semin Immunol       Date:  2014-10-30       Impact factor: 11.130

Review 5.  The balance between protective and pathogenic immune responses in the TB-infected lung.

Authors:  Ian M Orme; Richard T Robinson; Andrea M Cooper
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

6.  Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6'-dimycolate.

Authors:  R L Perez; J Roman; G W Staton; R L Hunter
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

7.  Immunopathology of BCG infection in genetically resistant and susceptible mouse strains.

Authors:  M Pelletier; A Forget; D Bourassa; P Gros; E Skamene
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

8.  Failure of CD1D-/- mice to elicit hypersensitive granulomas to mycobacterial cord factor trehalose 6,6'-dimycolate.

Authors:  Tera V Guidry; Margaret Olsen; Ki-Soo Kil; Robert L Hunter; Yong-Jian Geng; Jeffrey K Actor
Journal:  J Interferon Cytokine Res       Date:  2004-06       Impact factor: 2.607

9.  Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection.

Authors:  Michael J Davis; Tiffany M Tsang; Yafeng Qiu; Jeremy K Dayrit; Joudeh B Freij; Gary B Huffnagle; Michal A Olszewski
Journal:  MBio       Date:  2013-06-18       Impact factor: 7.867

10.  IL4I1 Is a Novel Regulator of M2 Macrophage Polarization That Can Inhibit T Cell Activation via L-Tryptophan and Arginine Depletion and IL-10 Production.

Authors:  Yinpu Yue; Wei Huang; Jingjing Liang; Jing Guo; Jian Ji; Yunliang Yao; Mingzhu Zheng; Zhijian Cai; Linrong Lu; Jianli Wang
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

View more
  5 in total

1.  Recombinant Human Lactoferrin Reduces Inflammation and Increases Fluoroquinolone Penetration to Primary Granulomas During Mycobacterial Infection of C57Bl/6 Mice.

Authors:  Thao K T Nguyen; Zainab Niaz; Marian L Kruzel; Jeffrey K Actor
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-02-28       Impact factor: 4.291

2.  Modulation of TDM-induced granuloma pathology by human lactoferrin: a persistent effect in mice.

Authors:  Jeffrey K Actor; Thao K T Nguyen; Agnieszka Wasik-Smietana; Marian L Kruzel
Journal:  Biometals       Date:  2022-08-17       Impact factor: 3.378

3.  Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology.

Authors:  Afsal Kolloli; Ranjeet Kumar; Pooja Singh; Anshika Narang; Gilla Kaplan; Alex Sigal; Selvakumar Subbian
Journal:  Commun Biol       Date:  2021-11-03

Review 4.  CD38: A Significant Regulator of Macrophage Function.

Authors:  Wentao Li; Yanling Li; Xi Jin; Qianjin Liao; Zhifang Chen; Honghua Peng; Yanhong Zhou
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

5.  Sub-Lineage Specific Phenolic Glycolipid Patterns in the Mycobacterium tuberculosis Complex Lineage 1.

Authors:  Nicolas Gisch; Christian Utpatel; Lisa M Gronbach; Thomas A Kohl; Ursula Schombel; Sven Malm; Karen M Dobos; Danny C Hesser; Roland Diel; Udo Götsch; Silke Gerdes; Yassir A Shuaib; Nyanda E Ntinginya; Celso Khosa; Sofia Viegas; Glennah Kerubo; Solomon Ali; Sahal A Al-Hajoj; Perpetual W Ndung'u; Andrea Rachow; Michael Hoelscher; Florian P Maurer; Dominik Schwudke; Stefan Niemann; Norbert Reiling; Susanne Homolka
Journal:  Front Microbiol       Date:  2022-03-08       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.